Item 7. Management’s Discussion and Analysis
Item 7. Management’s Discussion and Analysis
of Financial Condition and Results of Operations
This Management’s
Discussion and Analysis of Financial Condition and Results of Operations includes a number of forward-looking statements that reflect
Management’s current views with respect to future events and financial performance. You can identify these statements by forward-looking
words such as “may” “will,” “expect,” “anticipate,” “believe,” “estimate”
and “continue,” or similar words. Those statements include statements regarding the intent, belief or current expectations
of us and members of our management team as well as the assumptions on which such statements are based. Prospective investors are cautioned
that any such forward-looking statements are not guarantees of future performance and involve risk and uncertainties, and that actual
results may differ materially from those contemplated by such forward-looking statements.
Readers are urged to carefully
review and consider the various disclosures made by us in this report and in our other reports filed with the Securities and Exchange
Commission. Important factors known to us could cause actual results to differ materially from those in forward-looking statements. We
undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated
events or changes in the future operating results over time. We believe that its assumptions are based upon reasonable data derived from
and known about our business and operations and the business and operations of our company. No assurances are made that actual results
of operations or the results of our future activities will not differ materially from its assumptions. Factors that could cause differences
include, but are not limited to, expected market demand for our services, fluctuations in pricing for materials, and competition.
Our Business
SCWorx is a provider of data
content and services related to the repair, normalization and interoperability of information for healthcare providers and big data analytics
for the healthcare industry.
SCWorx has developed and markets
health information technology solutions and associated services that improve healthcare processes and information flow within hospitals.
SCWorx’s software platform enables healthcare providers to simplify, repair, and organize its data (“data normalization”),
allows the data to be utilized across multiple internal software applications (“interoperability”) and provides the basis
for sophisticated data analytics (“big data”). SCWorx’s solutions are designed to improve the flow of information quickly
and accurately between the existing supply chain, electronic medical records, clinical systems, and patient billing functions. The software
is designed to achieve multiple operational benefits such as supply chain cost reductions, decreased accounts receivables aging, accelerated
and more accurate billing, contract optimization, increased supply chain management and cost visibility, synchronous Charge Description
Master (“CDM”) and control of vendor rebates and contract administration fees.
SCWorx empowers healthcare
providers to maintain comprehensive access and visibility to an advanced business intelligence that enables better decision-making and
reductions in product costs and utilization, ultimately leading to accelerated and accurate patient billing. SCWorx’s software modules
perform separate functions as follows:
● virtualized
Item Master File repair, expansion and automation;
● CDM
management;
● contract
management;
● request
for proposal automation;
● rebate
management;
● big
data analytics modeling; and
● data
integration and warehousing.
SCWorx continues to provide
transformational data-driven solutions to many healthcare providers in the United States. The Company’s clients are geographically
dispersed throughout the country. The Company’s focus is to assist healthcare providers with issues that they have pertaining to
data interoperability. SCWorx provides these solutions through a combination of direct sales and relationships with strategic partners.
27
SCWorx’s software solutions
are delivered to its clients within a fixed term period, typically a three-to-five-year contracted term, where such software is hosted
in SCWorx data centers (Amazon Web Service’s “AWS” or RackSpace) and accessed by such clients through a secure connection
in a software as a service (“SaaS”) delivery method.
SCWorx currently sells its
solutions and services in the United States to hospitals and health systems through its direct sales force and its distribution and reseller
partnerships.
We currently host our solutions,
serve our customers, and support our operations in the United States through an agreement with a third party hosting and infrastructure
provider, RackSpace. We incorporate standard IT security measures, including but not limited to; firewalls, disaster recovery, backup,
etc. Our operations are dependent upon the integrity, security and consistent operation of various information technology systems and
data centers that process transactions, communication systems and various other software applications used throughout our operations.
Disruptions in these systems could have an adverse impact on our operations. We could encounter difficulties in developing new systems
or maintaining and upgrading existing systems. Such difficulties could lead to significant expenses or to losses due to disruption in
our business operations.
In addition, our information
technology systems are subject to the risk of infiltration or data theft. The techniques used to obtain unauthorized access, disable or
degrade service, or sabotage information technology systems change frequently and may be difficult to detect or prevent over long periods
of time. Moreover, the hardware, software or applications we develop or procure from third parties may contain defects in design or manufacture
or other problems that could unexpectedly compromise the security of our information systems. Unauthorized parties may also attempt to
gain access to our systems or facilities through fraud or deception aimed at our employees, contractors or temporary staff. In the event
that the security of our information systems is compromised, confidential information could be misappropriated, and system disruptions
could occur. Any such misappropriation or disruption could cause significant harm to our reputation, lead to a loss of sales or profits
or cause us to incur significant costs to reimburse third parties for damages.
Critical Accounting Policies and Estimates
Management’s discussion
and analysis of our consolidated financial condition and results of operations are based upon our consolidated financial statements. These
consolidated financial statements have been prepared in conformity with generally accepted accounting principles (“GAAP”)
in the United States which requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues
and expenses, and related disclosure of contingent assets and liabilities. By their nature, these estimates and judgments are subject
to an inherent degree of uncertainty. We evaluate our estimates based on our historical experience and various other assumptions that
are believed to be reasonable under the circumstances. These estimates relate to revenue recognition, the assessment of recoverability
of goodwill and intangible assets, the assessment of useful lives and the recoverability of property, plant and equipment, the valuation
and recognition of stock-based compensation expense, recognition and measurement of deferred income tax assets and liabilities, the assessment
of unrecognized tax benefits, and others. Actual results could differ from those estimates, and material effects on our consolidated operating
results and consolidated financial position may result. Refer to Note 2, Summary of Significant Accounting Policies, in the accompanying
consolidated financial statements, for a full description of our accounting policies.
Basis of Presentation
The accompanying consolidated
financial statements have been prepared in accordance to U.S. GAAP and the rules and regulations of the U.S. Securities and Exchange Commission
(“SEC”). The accompanying consolidated financial statements include the accounts of SCWorx and its wholly-owned subsidiaries.
All material intercompany balances and transactions have been eliminated in consolidation.
Principles of Consolidation
The accompanying consolidated
financial statements include the accounts of the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions
have been eliminated in consolidation.
Cash
Cash is maintained with various
financial institutions. Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash
deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation up to $250,000.
28
Fair Value of Financial Instruments
Management applies fair value
accounting for significant financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed
at fair value in the consolidated financial statements on a recurring basis. Management defines fair value as the price that would be
received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement
date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, management
considers the principal or most advantageous market in which we would transact and the market-based risk measurements or assumptions that
market participants would use in pricing the asset or liability, such as risks inherent in valuation techniques, transfer restrictions
and credit risk. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value
into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to
the fair value measurement: Level 1 - Quoted prices in active markets for identical assets or liabilities. Level 2 - Observable inputs
other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities
in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term
of the assets or liabilities. Level 3 - Inputs that are generally unobservable and typically reflect management’s estimate of assumptions
that market participants would use in pricing the asset or liability.
Concentration of Credit and Other Risks
Financial instruments that
potentially subject our company to significant concentrations of credit risk consist principally of cash, accounts receivable and warrants.
We believe that any concentration of credit risk in its accounts receivable is substantially mitigated by our evaluation process, relatively
short collection terms and the high level of credit worthiness of its customers. We perform ongoing internal credit evaluations of its
customers’ financial condition, obtain deposits and limit the amount of credit extended when deemed necessary but generally require
no collateral.
Significant customers are
those which represent more than 10% of the Company’s revenue for each period presented, or the Company’s accounts receivable
balance as of each respective balance sheet date. For each significant customer, revenue as a percentage of total revenue and accounts
receivable as a percentage of total net accounts receivable are as follows:
Revenue
For the years ended
Accounts Receivable
December 31,
December 31,
Customers
2022
2021
2022
2021
Customer A
12 %
7 %
12 %
4 %
Customer B
10 %
9 %
10 %
7 %
Customer C
14 %
5 %
15 %
16 %
Customer D
5 %
4 %
30 %
- %
Customer E
2 %
4 %
- %
17 %
Customer F
3 %
3 %
3 %
14 %
Allowance for Doubtful Accounts
Our company continually monitors
customer payments and maintains a reserve for estimated losses resulting from our customers’ inability to make required payments.
In determining the reserve, we evaluate the collectability of our accounts receivable based upon a variety of factors. In cases where
we become aware of circumstances that may impair a specific customer’s ability to meet its financial obligations, we record a specific
allowance against amounts due. For all other customers, we recognize allowances for doubtful accounts based on our historical write-off
experience in conjunction with the length of time the receivables are past due, customer creditworthiness, geographic risk and the current
business environment. Actual future losses from uncollectible accounts may differ from our estimates. The Company recorded an allowance
for doubtful accounts as of December 31, 2022 and 2021 of $0 and $421,736, respectively.
29
Leases
We determine if an arrangement
is a lease at inception. The current portion of lease obligations are included in accounts payable and accrued liabilities on the consolidated
balance sheets. Right-of-use (“ROU”) assets represent our right to use an underlying asset for the lease term, and lease liabilities
represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement
date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our
incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.
Our lease terms may include options to extend or terminate the lease, which are included in the lease ROU asset when it is reasonably
certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
We have lease agreements with lease components only, none with non-lease components, which are generally accounted for separately.
Business Combinations
Our company includes the results
of operations of a business we acquire in our consolidated results as of the date of acquisition. We allocate the fair value of the purchase
consideration of our acquisition to the tangible assets, liabilities and intangible assets acquired, based on their estimated fair values.
The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as
goodwill. The primary items that generate goodwill include the value of the synergies between the acquired businesses and our company.
Intangible assets are amortized over their estimated useful lives. The fair value of contingent consideration (earn out) associated with
acquisitions is remeasured each reporting period and adjusted accordingly. Acquisition and integration related costs are recognized separately
from the business combination and are expensed as incurred. For additional information regarding our acquisitions, refer to Note 4, Business
Combinations.
Goodwill and Identified Intangible Assets
Goodwill
Goodwill is recorded as the
difference between the aggregate consideration paid for an acquisition and the fair value of the net tangible and identified intangible
assets acquired under a business combination. Goodwill also includes acquired assembled workforce, which does not qualify as an identifiable
intangible asset. Management reviews impairment of goodwill annually in the fourth quarter, or more frequently if events or circumstances
indicate that the goodwill might be impaired. We first assess qualitative factors to determine whether it is necessary to perform the
quantitative goodwill impairment test. If, after assessing the totality of events or circumstances, we determine that it is not more likely
than not that the fair value of a reporting unit is less than its carrying amount, then the quantitative goodwill impairment test is unnecessary.
For further discussion of
goodwill, refer to Note 4, Business Combinations.
Property and Equipment
Property and equipment are
recorded at cost, less accumulated depreciation. Depreciation is calculated using the straight-line method over the related assets’
estimated useful lives. Equipment, furniture and fixtures are being amortized over a period of three years.
Expenditures that materially
increase asset life are capitalized, while ordinary maintenance and repairs are expensed as incurred.
30
Revenue Recognition
We recognize revenue in accordance
with Topic 606 to depict the transfer of promised goods or services in an amount that reflects the consideration to which an entity expects
to be entitled in exchange for those goods or services. To determine revenue recognition for arrangements within the scope of Topic 606
we perform the following steps:
● Step
1: Identify the contract(s) with a customer
● Step
2: Identify the performance obligations in the contract
● Step
3: Determine the transaction price
● Step
4: Allocate the transaction price to the performance obligations in the contract
●
Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation
We follow the accounting revenue
guidance under Topic 606 to determine whether contracts contain more than one performance obligation. Performance obligations
are the unit of accounting for revenue recognition and generally represent the distinct goods or services that are promised to the customer.
Management has identified
the following performance obligations in our contracts with customers:
1. Data
Normalization: which includes data preparation, product and vendor mapping, product categorization, data enrichment and other data related
services,
2. Software-as-a-service
(“SaaS”): which is generated from clients’ access of and usage of our hosted software solutions on a subscription basis
for a specified contract term, which is usually annually. In SaaS arrangements, the client cannot take possession of the software during
the term of the contract and generally has the right to access and use the software and receive any software upgrades published during
the subscription period,
3. Maintenance:
which includes ongoing data cleansing and normalization, content enrichment, and optimization, and
4. Professional
Services: mainly related to specific customer projects to manage and/or analyze data and review for cost reduction opportunities.
A contract will typically
include Data Normalization, SaaS and Maintenance, which are distinct performance obligations and are accounted for separately. The transaction
price is allocated to each separate performance obligation on a relative stand-alone selling price basis. Significant judgement is required
to determine the stand-alone selling price for each distinct performance obligation and is typically estimated based on observable transactions
when these services are sold on a stand-alone basis. At contract inception, an assessment of the goods and services promised in the contracts
with customers is performed and a performance obligation is identified for each distinct promise to transfer to the customer
a good or service (or bundle of goods or services). To identify the performance obligations, management considers all the goods or
services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. Revenue
is recognized when the performance obligation has been met. We consider control to have transferred upon delivery because we have
a present right to payment at that time, we have transferred use of the good or service, and the customer is able to direct the use of,
and obtain substantially all the remaining benefits from, the good or service.
Our SaaS and Maintenance contracts
typically have termination for convenience without penalty clauses and accordingly, are generally accounted for as month-to-month agreements.
If it is determined that we have not satisfied a performance obligation, revenue recognition will be deferred until the performance obligation
is deemed to be satisfied.
31
Revenue recognition for our
performance obligations are as follows:
Data Normalization and Professional Services
Our Data Normalization and
Professional Services are typically fixed fee. When these services are not combined with SaaS or Maintenance revenues as a single unit
of accounting, these revenues are recognized as the services are rendered and when contractual milestones are achieved and accepted by
the customer.
SaaS and Maintenance
SaaS and Maintenance revenues
are recognized ratably over the contract terms beginning on the commencement date of each contract, which is the date on which our service
is made available to customers.
Some contracts have payment terms that differ from the timing of revenue
recognition, which requires us to assess whether the transaction price for those contracts include a significant financing component.
We have elected the practical expedient that permits an entity to not adjust for the effects of a significant financing component if it
expects that at the contract inception, the period between when the entity transfers a promised good or service to a customer and when
the customer pays for that good or service will be one year or less. We do not maintain contracts in which the period between when the
entity transfers a promised good or service to a customer and when the customer pays for that good or service exceeds the one-year threshold.
As of December 31, 2021, we
had $579,833 of remaining performance obligations recorded as deferred revenue. We expect to recognize sales relating to these existing
performance obligations of during 2023.
Costs to Fulfill a Contract
Costs to fulfill a contract
typically include costs related to satisfying performance obligations as well as general and administrative costs that are not explicitly
chargeable to customer contracts. These expenses are recognized and expensed when incurred in accordance with ASC 340-40.
Cost of Revenue
Cost of revenues primarily
represent data center hosting costs, consulting services and maintenance of our large data array that were incurred in delivering professional
services and maintenance of our large data array during the periods presented.
Contract Balances
Contract assets arise when
the revenue associated prior to our unconditional right to receive a payment under a contract with a customer ( i.e ., unbilled revenue)
and are derecognized when either it becomes a receivable or the cash is received. There were no contract assets as of December 31, 2022
and 2021.
Contract liabilities arise
when customers remit contractual cash payments in advance of our company satisfying our performance obligations under the contract and
are derecognized when the revenue associated with the contract is recognized when the performance obligation is satisfied. Deferred revenue
for contract liabilities were $579,833 and $472,750 as of December 31, 2022 and 2021, respectively.
32
Income Taxes
Our company converted to a
corporation from a limited liability company during 2018.
We use the asset and liability
method of accounting for income taxes in accordance with Accounting Standard Codification (“ASC”) Topic 740, “Income
Taxes.” Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year
and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial
statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income
in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities
of a change in tax rates is recognized in the results of operations in the period that includes the enactment date.
Valuation allowances are provided
if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.
During the year ended December 31, 2022, we evaluated available evidence and concluded that we may not realize all the benefits of our
deferred tax assets; therefore, a valuation allowance was established for our deferred tax assets.
ASC Topic 740-10-30 clarifies
the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold
and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a
tax return. ASC Topic 740-10-40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods,
disclosure, and transition. We have no material uncertain tax positions for any of the reporting periods presented.
On December 22, 2017, the
Tax Cuts and Jobs Act of 2017, (the “Tax Act”) was enacted. The Tax Act significantly revised the U.S. corporate income tax
regime by, including but not limited to, lowering the U.S. corporate income tax rate from 34% to 21% effective January 1, 2018, implementing
a territorial tax system, imposing a one-time transition tax on previously untaxed accumulated earnings and profits of foreign subsidiaries,
and creating new taxes on foreign sourced earnings. During the years ended December 31, 2022 and 2021, we completed the accounting for
tax effects of the Tax Act under ASC 740. There were no impacts to the years ended December 31, 2022 and 2021.
Stock-based Compensation Expense
The Company accounts for stock-based
compensation expense in accordance with the authoritative guidance on share-based payments. Under the provisions of the guidance, stock-based
compensation expense is measured at the grant date based on the fair value of the option or warrant using a Black-Scholes option pricing
model and is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period.
The authoritative guidance
also requires that the Company measure and recognize stock-based compensation expense upon modification of the term of stock award. The
stock-based compensation expense for such modification is accounted for as a repurchase of the original award and the issuance of a new
award.
Calculating stock-based compensation
expense requires the input of highly subjective assumptions, including the expected term of the stock-based awards, stock price volatility,
and the pre-vesting option forfeiture rate. The Company estimates the expected life of options granted based on historical exercise patterns,
which are believed to be representative of future behavior. The Company estimates the volatility of the Company’s common stock on
the date of grant based on historical volatility. The assumptions used in calculating the fair value of stock-based awards represent the
Company’s best estimates, but these estimates involve inherent uncertainties and the application of management’s judgment.
As a result, if factors change and the Company uses different assumptions, its stock-based compensation expense could be materially different
in the future. In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those shares
expected to vest. The Company estimates the forfeiture rate based on historical experience of its stock-based awards that are granted,
exercised and cancelled. If the actual forfeiture rate is materially different from the estimate, stock-based compensation expense could
be significantly different from what was recorded in the current period. The Company also grants performance based restricted stock awards
to employees and consultants. These awards will vest if certain employee\consultant-specific or company-designated performance targets
are achieved. If minimum performance thresholds are achieved, each award will convert into a designated number of the Company’s
common stock. If minimum performance thresholds are not achieved, then no shares will be issued. Based upon the expected levels of achievement,
stock-based compensation is recognized on a straight-line basis over the requisite service period. The expected levels of achievement
are reassessed over the requisite service periods and, to the extent that the expected levels of achievement change, stock-based compensation
is adjusted in the period of change and recorded on the statements of operations and the remaining unrecognized stock-based compensation
is recorded over the remaining requisite service period. Refer to Note 8, Stockholders’ Equity, for additional detail.
33
Loss Per Share
We compute earnings
(loss) per share in accordance with ASC 260, “Earnings per Share” which requires presentation of both basic and diluted
earnings (loss) per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing the loss
available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period.
Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and
convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used
in determining the number of shares assumed to be purchased from the exercise of stock options and warrants and the exercise of
fully vested restricted stock units. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As of
December 31, 2022 and 2021, we had 4,095,867 and 3,322,670, respectively, common stock equivalents outstanding.
Indemnification
We provide indemnification
of varying scope to certain customers against claims of intellectual property infringement made by third parties arising from the use
of our software. In accordance with authoritative guidance for accounting for guarantees, we evaluate estimated losses for such indemnification.
We consider such factors as the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount
of loss. To date, no such claims have been filed against our company and no liability has been recorded in our financial statements.
As permitted under Delaware
law, we have agreements whereby we indemnify our officers and directors for certain events or occurrences while the officer or director
is, or was, serving at our company’s request in such capacity. The maximum potential amount of future payments we could be required
to make under these indemnification agreements is unlimited. In addition, we have directors’ and officers’ liability
insurance coverage that is intended to reduce our financial exposure and may enable us to recover any payments above the applicable policy
retention.
In connection with the Class
Action claims and investigations described in Item 3. Legal Proceedings of this Annual Report on Form 10-K, the Company is obligated to
indemnify its officers and directors for costs incurred in defending against these claims and investigations.
Contingencies
From time to time, we may
be involved in legal and administrative proceedings and claims of various types. We record a liability in our consolidated financial statements
for these matters when a loss is known or considered probable and the amount can be reasonably estimated. Management reviews these estimates
in each accounting period as additional information becomes known and adjusts the loss provision when appropriate. If the loss is not
probable or cannot be reasonably estimated, a liability is not recorded in the consolidated financial statements. If a loss is probable
but the amount of loss cannot be reasonably estimated, we disclose the loss contingency and an estimate of possible loss or range of loss
(unless such an estimate cannot be made). We do not recognize gain contingencies until they are realized. Legal costs incurred in connection
with loss contingencies are expensed as incurred. Refer to Note 7, Commitments and Contingencies, for further information.
Use of Estimates
The preparation of consolidated
financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and
disclosed in the consolidated financial statements and accompanying notes. The Company regularly evaluates estimates and assumptions related
to allowance for doubtful accounts, the estimated useful lives and recoverability of long-lived assets, equity component of convertible
debt, stock-based compensation, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on
current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results
of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses
that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from
the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results
of operations will be affected.
34
Recently Issued Accounting Pronouncements
From time to time, new accounting
pronouncements are issued by FASB that are adopted by the Company as of the specified effective date. If not discussed, management believes
that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial
statements upon adoption.
Results of Operations
The COVID-19 Pandemic has disrupted our
business and the business of our hospital customers.
Our operations and business
have experienced disruption due to the unprecedented conditions surrounding the COVID-19 pandemic which spread throughout the United States
and the world. The Company has followed the recommendations of local health authorities to minimize exposure risk for its team members
since the outbreak.
In addition, the Company’s
customers (hospitals) also experienced extraordinary disruptions to their businesses and supply chains, while experiencing unprecedented
demand for health care services related to COVID-19. As a result of these extraordinary disruptions to the Company’s customers’
business, the Company’s customers were focused on meeting the nation’s health care needs in response to the COVID-19 pandemic.
As a result, the Company believes that its customers were not able to focus resources on expanding the utilization of the Company’s
services, which has adversely impacted the Company’s growth prospects, at least until the adverse effects of the pandemic subside.
In addition, the financial impact of COVID-19 on the Company’s hospital customers could cause the hospitals to delay payments due
to the Company for services, which could negatively impact the Company’s cash flows.
The Company had sought to
mitigate these impacts to revenue through the sale of personal protective equipment (“PPE”) and COVID-19 rapid test kits to
the health care industry, including many of the Company’s hospital customers.
The Company is no longer actively
seeking to procure and sell Test Kits or PPE. The Company may receive commissions for acting as an intermediary with respect to the sale
of PPE and/or Test Kits. However, there is no assurance the Company will realize any material revenue from these activities.
Year Ended December 31, 2022 Compared to
Year Ended December 31, 2021
The following summary of our
results of operations should be read in conjunction with our consolidated financial statements for the years ended December 31, 2022 and
2021.
Our operating results for
the years ended December 31, 2021 and 2020 are summarized as follows:
Years ended
December 31,
2022
December 31,
2021
Difference
Revenue
$ 4,038,188
$ 4,632,529
$ (594,341 )
Cost of revenues
2,624,553
2,782,509
(157,956 )
General and administrative
3,540,232
5,664,488
(2,124,256 )
Other income (expense)
279,191
-
279,191
Provision for income taxes
-
-
-
Net loss
$ (1,847,406 )
$ (3,814,468 )
$ 1,967,062
Revenues
Revenue for the year ended
December 31, 2022 was $4,038,188, compared to $4,632,529 in revenue for the year ended December 31, 2021. The decline in revenue is primarily
related to a slight decrease in revenues from SaaS customer sales during the period.
35
Cost of Revenues
Cost of revenues for the year
ended December 31, 2022 was $2,624,553, compared to $2,782,509 for the year ended December 31, 2021. The $157,956 decrease is primarily
related to a decrease in labor costs during the current year.
Expenses
General and administrative
expenses decreased $2,124,256 to $3,540,232 for the year ended December 31, 2022, as compared to $5,664,488 in the same period of 2021.
This decrease was primarily due to a decrease in salary expense of approximately $64,000, a decrease in stock-based compensation (non-cash)
of approximately $1,546,000, a decrease in accounting fees of $144,000, a decrease in inventory write down expense of $170,000, a decrease
in bad debt expense of $204,000, and a decrease in commission expense of $210,000. We expect general and administrative expenses (excluding
non-cash compensation expenses) to remain relatively flat during 2023 with the exception of increases in our sales force.
We had other income of $279,191
during the year ended December 31, 2022 related to the forgiveness of PPP loans.
Liquidity and Capital Resources
Going Concern
Management has concluded on
our consolidated financial statements for the year ended December 31, 2022 that conditions exist that raise substantial doubt about our
ability to continue as a going concern since we may not have sufficient capital resources from operations and existing financing arrangements
to meet our operating expenses and working capital requirements. As of December 31, 2022, we had a working capital deficit of $1,442,198
and accumulated deficit of $25,858,697. During the year ended December 31, 2022, we had a net loss of $1,847,406 and used $546,673 of
cash in operations. We have historically incurred operating losses and may continue to incur operating losses for the foreseeable future.
We believe that these conditions raise substantial doubt about our ability to continue as a going concern. This may hinder our future
ability to obtain financing or may force us to obtain financing on less favorable terms than would otherwise be available. If we are unable
to develop sufficient revenues and additional customers for our products and services, we may not generate enough revenue to sustain our
business, and we may fail, in which case our stockholders would suffer a total loss of their investment. There can be no assurance that
we will be able to continue as a going concern.
Recent Fundraising
Between September 7, 2022
and September 12, 2022, the Company issued an aggregate 1,153,845 shares of common stock as commitment shares pursuant to a private placement
agreement. The shares had a fair value of $750,000 or $0.65 per share. Company received aggregate net proceeds related to this placement
of $725,050.
Liquidity
We are currently experiencing
a working capital deficiency, have limited cash on hand, and we are experiencing negative cash flows from operations. Consequently, we
have an immediate need for additional capital to fund our operations and the implementation of our business plan.
Based on our current business
plan, if we had sufficient capital resources, we anticipate that our operating activities would use a net of approximately $50,000 in
cash per month over the next twelve months, or approximately $600,000. Currently we have only limited cash on hand, and consequently,
we are unable to implement our current business plan. Accordingly, we have an immediate need for additional capital to fund our operating
activities.
In order to remedy this liquidity
deficiency, we have cut spending and are actively seeking to raise additional funds through the sale of equity and debt securities. Ultimately,
we will need to generate substantial positive operating cash flows. Our internal sources of funds will consist of cash flows from operations,
but not until we begin to realize substantial additional revenues from the sale of our products and services. As previously stated, our
operations are generating negative cash flows, and thus adversely affecting our liquidity. If we are able to secure sufficient funding
in the first half of 2023 to fully implement our business plan, we expect that our operations could begin to generate positive cash flows
by the end of 2023, which should ameliorate our liquidity deficiency. If we are unable to raise additional funds in the near term, we
will not be able to fully implement our business plan, in which case there could be a material adverse effect on our results of operations
and financial condition.
36
In the event we do not generate
sufficient funds from revenues or financing through the issuance of common stock or from debt financing, we will be unable to fully implement
our business plan and pay our obligations as they become due, any of which circumstances would have a material adverse effect on our business
prospects, financial condition, and results of operations. The accompanying financial statements do not include any adjustments that might
be required should the Company be unable to recover the value of its assets or satisfy its liabilities.
Based on our current limited
availability of funds, we expect to spend minimal amounts on expansion of our sales organization, software development and capital expenditures.
We expect to fund any future software development expenditures through a combination of cash flows from operations and proceeds from equity
and/or debt financing. If we are unable to generate positive cash flows from operations, and/or raise additional funds (either through
debt or equity), we will be unable to fund our software development expenditures, in which case, there could be an adverse effect on our
business and results of operations.
Cash Flows
Years ended December 31,
2022
2021
Net cash used in operating activities
$ (546,663 )
$ (1,069,945 )
Net cash used in investing activities
-
-
Net cash provided by financing activities
725,050
764,595
Change in cash
$ 178,387
$ (305,350 )
Our operations through December
31, 2022 have resulted in negative cash flows from operations of $546,663. If we are able to raise additional capital during first half
of 2023 and generate additional revenue through the acquisition of new customers, we believe we may begin to generate positive operating
cash flows by the end of 2023. However, there is no assurance we will be able to increase our revenue sufficiently so as to generate positive
operating cash flows within this time frame.
Operating Activities
Net cash used in operating
activities was $546,663 for the year ended December 31, 2022, mainly related to the net loss of $1,847,406 and a gain on forgiveness of
PPP Loans of $285,818, partially offset by non-cash stock-based compensation of $1,141,932 related to various equity awards to employees
and non-employees, $78,125 in bad debt expense, and a $156,600 decrease in inventory valuation.
Net cash used in operating
activities was $1,069,945 for the year ended December 31, 2021, mainly related to the net loss of $3,814,46 and decreases of $452,284
in accounts payable and accrued liabilities and $690,083 in deferred revenue, partially offset by non-cash stock-based compensation of
$2,687,901 related to various equity awards to employees and non-employees, $163,917 in bad debt expense, and a $475,000 decrease in inventory
valuation.
37
Investing Activities
The Company did not have any
investing activities during the years ended December 31, 2022 and 2021.
Financing Activities
Net cash provided by financing
activities was $725,050 for the year ended December 31, 2022. This consisted proceeds from a common stock placement.
Net cash provided by financing
activities was $764,595 for the year ended December 31, 2021. This consisted of $139,595 in proceeds from a loan payable, $100,000 advanced
by the Company’s former CEO (also a significant shareholder), and $525,000 from a common stock placement.
Contractual Cash Obligations
Refer to Note 7, Commitments
and Contingencies, in the accompanying consolidated financial statements for additional detail.
Off-Balance Sheet Arrangements
As of December 31, 2022, we
did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.
Item 7A. Quantitative and Qualitative Disclosures
About Market Risk
We are a smaller reporting
company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.
Item 8. Financial Statements and Supplementary
Data
The consolidated financial
statements are included in Part IV, Item 15 (a) (1) of this Report.
Item 9. Changes in and Disagreements with Accountants
on Accounting and Financial Disclosure
None
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.